Personalized fMRI-Guided TMS May Improve Severe OCD Symptoms
Posted on 11 Nov 2026
Obsessive-compulsive disorder (OCD) is a chronic psychiatric disorder marked by intrusive thoughts and repetitive behaviors. Severe cases can remain difficult to manage when medication and psychotherapy fail, and some patients may require deep brain stimulation involving brain surgery. To offer a nonsurgical option, researchers have developed a personalized stimulation approach that targets each patient’s specific brain circuits.
The National University Hospital (NUH; Singapore) and Yong Loo Lin School of Medicine at the National University of Singapore (NUS Medicine) are evaluating personalized transcranial magnetic stimulation (pTMS) in two studies. The approach begins with functional magnetic resonance imaging (fMRI) at the NUS Medicine Centre for Translational Magnetic Resonance Research to map each participant’s brain circuitry. An algorithm developed at NUS Medicine then analyzes the scans to identify individualized stimulation targets.
Magnetic pulses are delivered to the selected target using a neuro-navigation robotic arm at NUH’s Centre for Interventional Psychiatry. Treatment involves intermittent theta-burst stimulation (iTBS), a shorter form of transcranial magnetic stimulation that reduces session duration from the conventional 37.5 minutes to about nine minutes.
The completed OCD study evaluated causal-circuit, fMRI-guided iTBS in four participants with severe, treatment-resistant disease. Two withdrew before completing treatment, while two completed 40 short sessions over five days. One had a 78% reduction in Obsessive-Compulsive Inventory–Revised scores by the end of treatment week and reported no symptoms on the questionnaire six weeks later. The other experienced a 35% symptom reduction four weeks after treatment. After symptoms returned at about 12 weeks, this participant received a two-day booster treatment and again showed substantial improvement.
Building on this work, NUH and NUS Medicine are evaluating the approach in depression with co-occurring anxiety symptoms. The study began in October 2026 and aims to recruit 30 participants through early 2029. Repeated fMRI and symptom assessments, including up to 48 hours of MRI scans over 10 months, will examine two personalized stimulation targets linked to depression- and anxiety-related circuits.
“For people with severe OCD who have tried medication and therapy without success, there have been very few genuinely new treatment options in decades. Being able to reach the circuits that deep brain stimulation targets, without surgery and in a single week of treatment, is what makes these early results so encouraging,” said Adjunct Associate Professor Tor Phern Chern, Senior Consultant, Department of Psychological Medicine, NUH.
“These studies represent an important step towards a more precise and individualised approach to mental health care. By combining brain imaging with computational modelling, we are able to better understand how each patient's symptoms are reflected in their brain circuitry, and translate that insight into targeted treatment. This integrated approach has the potential to reshape how we deliver TMS and improve outcomes for patients who have not benefitted from conventional methods,” said Associate Professor Thomas Yeo, Deputy Head, Centre for Translational Magnetic Resonance Research, NUS Medicine.
Related Links
NUS Medicine
National University Hospital